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Chronic rhinosinusitis is a multifactorial process disease in which bacterial infection or colo-
nization may play an important role in the initiation or persistence of inflammatory response.
The association between mucosal bacteria presence and inflammatory patterns has only
been partially explored.
Objective
To demonstrate specific mucosal microorganisms possible association with inflammatory
patterns.
Methods
We collected nasal polyps or sinus tissues from a clinical selection of six patient groups with
defined sinus disease using tissue biomarkers. In the tissues, we detected bacteria using
peptide nucleic acid fluorescence in situ hybridization (PNA-FISH).
Results
After reviewing a total of 115 samples (15–20 samples per group), the mucosal presence of
Staphylococcus aureus was correlated with IL-5 and SE-IgE positive chronic rhinosinusitis
with nasal polyps and nasal polyps from cystic fibrosis patients. Chronic rhinosinusitis with-
out nasal polyps with TNFα >20 pg/ml was associated with the mucosal presence of Pseu-
domonas aeruginosa.
Conclusion
This study identifies the relationship between intramucosal microbes and inflammatory pat-
terns, suggesting that bacteria may affect the type of inflammation in chronic rhinosinusitis.
Additional investigation is needed to further identify the nature of the relationship.
PLOS ONE | DOI:10.1371/journal.pone.0136068 August 14, 2015 1 / 11
OPEN ACCESS
Citation: Chalermwatanachai T, Zhang N, Holtappels
G, Bachert C (2015) Association of Mucosal
Organisms with Patterns of Inflammation in Chronic
Rhinosinusitis. PLoS ONE 10(8): e0136068.
doi:10.1371/journal.pone.0136068
Editor: Christianne Bandeira de Melo, Universidade
Federal do Rio de Janeiro, BRAZIL
Received: March 19, 2015
Accepted: July 29, 2015
Published: August 14, 2015
Copyright: © 2015 Chalermwatanachai et al. This is
an open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: Supported by grants to C. Bachert from the
European Commission’s Seventh Framework
programme under grant agreement no. 260895
(PREDICTA); from the Flemish Scientific Research
Board, FWO, No. A12/5-HB- KH3, project G.0436.04,
3G.0489, G.0642.10N; by the Global Allergy and
Asthma European Network (GA2LEN); and by the
Interuniversity Attraction Poles Program–Belgian
State Belgian Science Policy, No. IAP P7/30. It was
also supported by scholarship to C. Thanit by the
Royal Thai Government. The funders had no role in
Introduction
Rhinosinusitis is a broad general term used to describe various inflammatory diseases of the
nasal and paranasal cavities. The European Position Paper on Rhinosinusitis and Nasal Polyps
(EPOS) concurs that rhinosinusitis is characterized by two or more symptoms: either nasal
blockage/obstruction, or nasal discharge; facial pain/pressure, reduction or loss of smell, or
both [1]. The chronic status of the disease is defined when symptoms persist at least 12 weeks
without complete amelioration.
The role of infectious agents in patients with acute rhinosinusitis (ARS) is well established but
the role in chronic rhinosinusitis (CRS) remains unclear. CRS affects 10.9% of the European pop-
ulation, which increases direct medical costs and affects overall general health outcomes [2].
CRS can be classified into two clinical subgroups (phenotypes) based on the absence and
presence of nasal polyps (CRSsNPs and CRSwNPs) [1]. These two subgroups may be further
divided into several disease endotypes based on the cytokine composition predominant within
the tissue [3]. The phenotype is useful in treatment planning while the endotype provides
insight in pathophysiological mechanisms of CRS. Therefore, investigations of the pathogene-
sis and the factors amplifying mucosal inflammation are therefore, of crucial importance for
the development of new diagnostic and therapeutic tools.
In our previous findings, using the peptide nucleic acid-fluorescence in situ hybridization
(PNA-FISH), we reported a higher quantity of Staphylococcus aureus (S. aureus) in nasal pol-
yps (NPs) tissues from patients with aspirin exacerbated respiratory disease [4]. We also found
an association between gram-positive bacterial colonization and interleukin (IL)-5-positive
NPs, whereas gram-negative bacteria were associated with IL-5-negative NPs [5]. Thus, specific
inflammatory endotypes are likely to be associated with the intramucosal presence of specific
bacteria but it remains unclear which organisms are related to the different endotypes.
Microorganisms have a possible influential role at least in selected subsets or endotypes of
CRS; mucosal bacteria might have a specifically direct and strong impact on the mucosal
immune system. To validate this hypothesis, we attempted to illustrate the association of spe-
cific microorganisms and specific inflammatory patterns. The main emphasis of the current
study was on intra-mucosal microorganisms such as S. aureus, Pseudomonas aeruginosa (P.
aeruginosa) and Escherichia coli (E. coli), and fungi all detectable by the PNA-FISH.
Materials and Methods
Nasal tissue
Nasal tissue samples (n = 115) with defined disease and pathology were selected from a tissue
collection at the Department of Otorhinolaryngology, Ghent University Hospital. The study
for collecting human tissue samples was approved by the ethics committee of the University of
Ghent, Belgium and appointed the number B67020111209. All patients gave written informed
consent before being operated on. These samples were obtained from patients during endona-
sal sinus surgery. The inferior turbinates from patients undergoing septoplasty without sinus
disease were used as control. The diagnosis of CRS in each patient was in compliance with the
EPOS guidelines. Diagnosis of cystic fibrosis (CF) and asthma was subsequently confirmed by
a pediatrician/pulmonologist. The atopic status was evaluated using the Phadiotop test (Pha-
dia; Uppsala, Sweden). Cytokine profiles were performed on all disease tissue samples. CRS tis-
sue samples were classified according to their cytokine composition in five groups: sinus
tissues from CRSsNPs patients with tumor necrosis factor alpha (TNFα) mucosal concentra-
tions<20pg/ml or>20pg/ml, CRSwNPs tissues with IL-5 and SE-IgE expression, nasal polyp
tissues without IL-5 and SE-IgE expression, and nasal polyps from patients with CF.
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Measurement of Cytokines in Tissue
Snap-frozen tissue specimens were weighed and suspended in a ratio 0.1 g of tissue per 1 mL of
0.9% NaCl solution with a complete protease inhibitor cocktail (Roche; Mannheim, Germany).
To prepare soluble protein fractions, the frozen tissues were pulverized using mechanical Tis-
sue Lyser LT (Qiagen Hilden, Germany) at 50 oscillations per second for two minutes in pre-
chilled Eppendorf tubes. Homogenized tissues were centrifuged at 15,000 rpm for five minutes
at 4°C, and the supernatants were collected. Total IgE, eosinophil cationic protein (ECP) and
specific IgE to staphylococcal enterotoxins (SE-IgE) were measured using the UniCAP system
(Phadia; Uppsala, Sweden). Assay of the TNFα, interleukin (IL)-5, and IL-17 were performed
using Luminex (R&D system; Minneapolis, MN, USA). Interferon gamma (IFNγ) was deter-
mined using ELISA (R&D system; Minneapolis, MN, USA). IL-22 was assayed using Duoset-
Elisa from R&D system.
Identification of Microorganisms by Peptide Nucleic Acid Fluorescence
in situ Hybridization
Nasal mucosal tissues were prepared using frozen section procedure and cut to 5μm, fixed with
70% ethanol for ten minutes and air-dried. Subsequently, the dried sections were hybridized at
55°C for 90 minutes in a humidified chamber with 100–500 nM of fluorescein-labeled PNA
probe (Uniprobe, which hybridizes with a wide range of gram positive and gram negative bac-
teria; S. aureus; P. aeruginosa and E. coli; and panFungus PNA-FISH kit; AdvanDx; Woburn,
MA, USA). After hybridization, the coverslips were removed by submerging each slide in the
stringent wash buffer provided in the kit and washed for 30 minutes in a shaking water bath at
55°C. Each slide was subsequently mounted in Vectashield (Vector; Burlingame, CA, USA)
containing 4,6-diamidino-2-phenylindole dihydrochloride (Roche Molecular Biochemicals;
Brussels, Belgium) to counterstain the nuclei. A negative control (without PNA probe) was run
in parallel to each sample. Microscopic examination was conducted with a Zeiss Axioplan epi-
fluorescence microscope (Carl Zeiss; Gottingen, Germany) equipped with a CCD camera
(IMACCCD S30; SONY, Germany) using a fluorescein isothiocyanate specific filter. Images
were captured using the Isis imaging and software system (MetaSystems; Sandhausen, Ger-
many). The samples were assessed using a score of bacterial appearance in the mucosa from 0
to 3: 0, negative; 1, extraepithelial presence; 2, intraepithelial presence and 3, subepithelial pres-
ence. Ten high-power fields were counted and added resulting in a total mucosal score between
0 and 30. Furthermore, we interpreted mucosal invasion as; negative (all 10 fields scored 0),
noninvasive (at least 1 field scored 1), or intramucosal invasive (at least 1 field scored 2 or 3)
based on the maximum score. Two independent observers, not privileged to the diagnosis and
clinical data, evaluated the slides.
Statistical Analysis
Statistical analysis was performed with GraphPad Prism version 6.00 for Mac OS X (GraphPad
Software; La Jolla CA, USA, www.graphpad.com). The categorical data (sex, positive atopy,
asthma, and probe) were expressed as frequencies or percentages and were analyzed using the
Chi-square test. The interval data (age, level of cytokines, and total mucosal score) were tested
for distribution using the Shapiro-Wilk normality test revealing that the data were distributed
non-normally. The Kruskal-Wallis test was used to assess the significance of intergroup corre-
lation, and corrections of significance for between-group comparisons were calculated using
Dunn's test. The Spearman’s rank correlation was employed to assess the statistical correlation
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between cytokine and mucosal score. The statistical significance level was determined as p
<0.05.
Results
Characteristics in the Nasal Tissue Samples
Table 1 illustrates the number of samples and clinical characteristics of the patients. More than
half (62.5%) of the patients with IL-5 and SE-IgE positive NPs had co-morbid asthma. CF
patients were the youngest as expected. No significant differences were found with regard to
sex and atopy in intergroup comparisons of patients.
Cytokine Patterns in the Nasal Tissue Samples
Typical patterns of cytokines for CRSsNPs are T helper 1(Th1)-driven, whereas CRS with
eosinophilic NPs is T helper 2(Th2)-biased and CRS with neutrophilic NPs expresses increased
amounts of IFNγ and/or IL-17 or none of those. NPs from CF patients demonstrate high con-
centrations of IL-17 and IL-8 [6]. In the current study, concentrations of ECP and IgE were sig-
nificantly higher in NPs with IL-5 expression compared with all other groups. Additionally, an
increase in SE-IgE concentration was observed. The number of SE-IgE positive subjects was
significantly higher in this group compared with the controls and the other groups. TNFα was
detected in sinus tissues from CRS patients and IL-5 positive NPs. IFNγ was noted in the sinus
tissue homogenates with a concentration of TNFα>20 pg/ml, IL-5 negative NPs, and CF-NPs.
The expression of IL-22 showed a significant increase in the TNFα>20 pg/ml sinus tissue
homogenates compared with all other groups. A remarkably decreased level of IL-22 was
observed in NP from CF patients compared with the control and CRSsNP patients. Although
IL-17 expression was higher in NP from CF patient, it did not reach the level of statistical sig-
nificance (p = 0.0545)(Fig 1).
PNA-FISH Probe Results
S. aureus was detected in a number of samples from the IL-5 and SE-IgE positive NPs (75%)
and CF-NPs groups (60%) compared with the control group (15%, p = 0.0001 and p = 0.0055
respectively). The presence of P. aeruginosa in samples of sinus tissue with TNFα concentra-
tions>20 pg/ml (70%) was significantly higher than in the control group (35%, p = 0.0267).
The PNA-FISH probe for E. coli and panfungus revealed no statistically significant difference
among all groups. Furthermore, the Uniprobe discovering all bacteria did not show any differ-
ence in numbers, indicating that all samples had about the same total bacterial load. Represen-
tative PNA probe findings are shown in Fig 2.












No. of sample 20 20 20 20 20 15
Mean age (yr) 32.75 44.45 39.35 41.05 51.2 13.25 p<0.0001




5.88% 20% 31.25% 29.41% 52.94% n/a NS
p = 0.6776
Asthma 0% 20% 20% 35.29% 62.50% n/a p = 0.0330
doi:10.1371/journal.pone.0136068.t001
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The total mucosal scores (median [interquartile range]) for S. aureus in the IL-5 and SE-IgE
positive NPs (3 [0–13]) and among CF-NPs (3 [0–19]) were significantly different from the control
group (0[0–7]). Asthma had no significant impact on the scores in the IL-5 and SE-IgE positive
NPs. Invasion of the mucosa by P. aeruginosa was significantly more frequent in the TNFα>20
pg/ml sinus tissues (median 8 [0–15]) compared with control tissues (median 0 [0–6])(Fig 3).
Correlations between Cytokine Levels and Total Mucosal Score
Correlations of cytokines and scores of bacterial appearance in the mucosa reveal that IL-5 and
ECP were positively correlated with the S. aureus score (r = 0.2181, p = 0.0293; and r = 0.3417,
p = 0.0025, respectively). In contrast, IL-22 was negatively correlated with the S. aureus score
(r = -0.3033, p = 0.0012). The P. aeruginosa score positively correlated with TNFα (r = 0.2495,
p = 0.0276) and IFNγ (r = 0.2839, p = 0.0025). However, no cytokine detectable in tissue corre-
lated with the Uniprobe score (Fig 4).
Discussion
Using PNA-FISH detection we demonstrated that the presence of S. aureus was associated
with IL-5 and SE-Ig E positive CRSwNPs and NPs from patients with CF, whereas P.
Fig 1. Cytokine expression in sinus tissues. The graphs represent median, upper and lower quartiles. High IgE, IL-5 and ECP concentrations characterize
the inflammation in IL5&SE-IgE positive NPs. In CRS with TNFα >20 pg/mL, the expression of IFNγ and IL-22 are elevated. Statistical analysis was
performed using Kruskal-Wallis and Dunn’s multiple comparisons test. An asterisk (*) refers to p values0.05. The p values between 0.001 and 0.01 are
displayed with two asterisks (**), p values between 0.0001 and 0.001 are shown with three asterisks (***), and p values less than 0.0001 are labeled with
four (****) asterisks.
doi:10.1371/journal.pone.0136068.g001
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aeruginosa was specifically found in the nasal tissues of CRSsNPs with TNFα concentrations
above 20 pg/ml.
S. aureus, a gram-positive cocci bacterium, expresses a range of virulence factors that chal-
lenge the immune system [7]. Our results were consistent with earlier findings that S. aureus
could drive Th2 type inflammation [3, 5, 8]. The association of S. aureus superantigens and
CRSwNPs was recently confirmed in a meta-analysis [9]. Furthermore, our findings confirm
that S. aureus colonized the airways of young patients with CF [10]. However, whereas mucosal
S. aureus enterotoxin-specific IgE could be found in adult patients with CRSwNPs, those anti-
bodies could not be detected in patients with CF. The reasons for this observation may lie in
the ability of S. aureus to produce enterotoxins or in the immunological environment. For
CRSwNPs, the presence of IL-5 and SE-Ig E but not S. aureus in tissue was associated with
comorbid asthma [4, 11]. Moreover, the level of IL-5 and SE-Ig E was demonstrated to be sig-
nificantly increased in recurrent versus nonrecurrent CRSwNPs [12].
P. aeruginosa is a gram-negative, motile rod bacterium. This study revealed the clinical
meaningful presence of P. aeruginosa in sinus tissues with TNFα concentrations higher than
20pg/ml, coinciding with elevated levels of IFNγ and IL-22. These findings confirm a Th1
milieu in CRSsNPs and suggest that P. aeruginosamay drive Th1 type inflammation and a spe-
cific antibacterial response [13]. P. aeruginosa does not only stimulate TNFα production in epi-
thelial cells [14], but also induces dendritic cell maturation to the Th1-polaizing phenotype
[15]. Moreover, P. aeruginosa activates dendritic cells, Th1 cells, and group 3 innate lymphoid
Fig 2. PNA-FISH. The graphs illustrate percentages of samples of bacterial presence for each of the probes in the different patient groups. The highest
percentage of positive samples for S. aureuswas identified among the IL5&SE-IgE positive NPs and patients with NPs and CF, whereas P. aeruginosa was
discovered in high numbers in CRS samples with TNFα>20pg/mL. Differences from the control group were calculated using the Chi-square test. The * p
values0.05, ** p values between 0.001 and 0.01,*** p values between 0.0001 and 0.001 were recorded
doi:10.1371/journal.pone.0136068.g002
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cells (ILC) in the mucosa to produce IL-22 [16, 17]. IL-22, a member of the IL-10 family [18] is
essential for mucosal immunity. It boosts the innate immunity [17] and induces epithelial cells
to produce antimicrobial proteins [19]. In murine models, IL-22 was demonstrated to play a
vital role in the fight against gram-negative bacteria in the respiratory system [20, 21]. The
decreased expression of IL-22 in CF-NPs may predispose these patients to gram-negative infec-
tion in adults. This study illustrated that intramucosal P. aeruginosa colonization relates to
TNFα and IFNγ levels in the tissue. TNFα has been defined as a key regulatory cytokine of
inflammatory responses and plays an important role of normal host defense against microor-
ganisms [22]. Our data suggest that either TNFα or IFNγmay serve as markers for P. aerugi-
nosa infections in CRSsNPs.
Uniprobe detects a broad range of bacteria. The fact that we found equivalent amounts of
bacteria in control and diseased tissues was supported by recent findings on the sinus micro-
biome, showing similar results [23]. Whereas the number of germs per surface area may be
similar, the richness and evenness of these germs differentiate healthy from diseased
Fig 3. Total mucosal scores for the presence of bacteria in sample tissues, detected by PNA-FISH. Each point represents the score from the individual
sample. The data for each group are expressed as median and interquartile range. The total score of S. aureuswas specifically high in IL5&SE-IgE positive
NPs and CF-NPs compared with the controls. CRS with TNFα >20 pg/mL showed the highest score for P. aeruginosa compared with the controls and NPs,
but not with CF-NP. The significance between groups was tested using Kruskal-Wallis test. Dunn’s test was employed to correct the significance for
between-group comparisons. The * p values 0.05, ** p values between 0.001 and 0.01 were recorded.
doi:10.1371/journal.pone.0136068.g003
Bacteria and Inflammatory Pattern in CRS
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Fig 4. The correlations between cytokines and total mucosal scores of each PNA-probe. The correlations were calculated using Spearman’s rank test.
Correlation coefficient (r) and p value were given for each correlation. NS stands for Not Significant (p >0.05).
doi:10.1371/journal.pone.0136068.g004
Bacteria and Inflammatory Pattern in CRS
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conditions. The intramucosal presence of bacteria has been not only demonstrated before in
disease, but also in healthy conditions [4, 24].
The prevalence of fungi in CRS has long been considered. In our experiment, the pan-fungal
PNA-FISH probe only detected a small proportion of fungi without differences between groups
by hybridizing with 28S rDNA genes [25]. Although studies have reported a predominance of
fungi in CRS patients [26, 27], the prevalence of fungal DNA in CRS patients was shown to be
lower than 10% [28]. Although it should be taken into account that we have slightly underesti-
mated the number of fungi present due to the failure of PNA-FISH probes to penetrate the
rigid fungal cell walls [29], this study disproves the hypothesis that fungi are principal offenders
in the development of CRS.
Future directions for research should involve 16S rRNA gene pyrosequencing and quantita-
tive real-time PCR approaches and study the immune proteomes of the germs and the patho-
mechanisms involved in the crosstalk with the host. Exploration of the relationships between
microbes and their impact on sino-nasal immune responses may lead to a greater understand-
ing of the pathogenesis of CRS, and thus, result in new strategies for its treatment.
Conclusion
For the first time, this study identified a relationship between intramucosal microorganisms
and inflammatory patterns in subgroups of patients with CRS. Variations of intramucosal bac-
teria have been identified between the different CRS endotypes. S. aureus is associated with
Th2-bias CRSwNPs and NPs from patients with CF while P. aeruginosa is related to high
inflammatory CRSsNPs. We propose TNFα and/or IFNγ as a biomarker for CRSsNPs. The
interaction of microbes with the mucosal immune responses should be further evaluated.
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